• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

当诊断出 DCIS 时,我们能知道该怎么做吗?

Can we know what to do when DCIS is diagnosed?

机构信息

Department of Pathology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA.

出版信息

Oncology (Williston Park). 2011 Aug;25(9):852-6.

PMID:21936451
Abstract

Utilizing routine histopathologic parameters obtained from appropriately handled lumpectomy and mastectomy specimens, a rational therapeutic plan based on epidemiologic and outcome-based data can be devised for any patient diagnosed with ductal carcinoma in situ (DCIS). In order to make a sound decision when weighing the current treatment options for DCIS--which include excision alone, excision plus radiation, and mastectomy--the following are mandatory: 1) assurance of an accurate diagnosis, 2) assessment of DCIS size and grade, and 3) careful margin evaluation. Accurate grading of DCIS is critical, since high nuclear grade and the presence of necrosis are highly predictive of the inability to achieve adequate margins, of local recurrence, and of the probability of missed areas of invasion. Margin status is the single most important determinant of local control following breast conservation for DCIS; numerous studies have shown that as the margin width increases, the risk of local failure decreases. The pros and cons of irradiating conservatively treated patients with DCIS should be carefully weighed on a case-by-case basis. Despite the 20-year-old dogma that all patients treated with breast conservation should receive postoperative radiation, a subset of patients who can be successfully treated by excision alone has been identified.

摘要

利用适当处理的保乳手术和乳房切除术标本获得的常规组织病理学参数,可以为任何诊断为导管原位癌(DCIS)的患者制定基于流行病学和基于结果的数据的合理治疗计划。为了在权衡 DCIS 的当前治疗选择时做出明智的决策——这些选择包括单纯切除、切除加放疗和乳房切除术——以下是强制性的:1)确保准确的诊断,2)评估 DCIS 的大小和分级,以及 3)仔细评估边缘。准确分级 DCIS 至关重要,因为核高级别和坏死的存在高度预测无法达到足够的边缘、局部复发和错过侵袭区域的概率。边缘状态是保乳治疗 DCIS 后局部控制的唯一最重要决定因素;许多研究表明,随着边缘宽度的增加,局部失败的风险降低。应根据具体情况仔细权衡对接受保守治疗的 DCIS 患者进行放疗的利弊。尽管存在 20 年的陈旧观念,即所有接受保乳治疗的患者都应接受术后放疗,但已经确定了一部分可以通过单纯切除成功治疗的患者。

相似文献

1
Can we know what to do when DCIS is diagnosed?当诊断出 DCIS 时,我们能知道该怎么做吗?
Oncology (Williston Park). 2011 Aug;25(9):852-6.
2
Optimal management of ductal carcinoma in situ of the breast.乳腺导管原位癌的优化管理
Surg Oncol. 2003 Dec;12(4):221-40. doi: 10.1016/S0960-7404(03)00031-8.
3
Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.乳腺导管原位癌:不断演变的观点
Cancer Treat Rev. 2000 Apr;26(2):103-25. doi: 10.1053/ctrv.1999.0149.
4
Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.保乳治疗的导管原位癌患者切缘阴性的界定:芝加哥大学的经验
Breast J. 2005 Jul-Aug;11(4):242-7. doi: 10.1111/j.1075-122X.2005.21617.x.
5
Recent advances and current controversies in the management of DCIS of the breast.乳腺导管原位癌治疗的最新进展与当前争议
Cancer Treat Rev. 2008 Oct;34(6):483-97. doi: 10.1016/j.ctrv.2008.03.001. Epub 2008 May 19.
6
Treatment of ductal carcinoma in situ of the breast: review of recent advances and future prospects.乳腺导管原位癌的治疗:近期进展与未来前景综述
Int J Fertil Womens Med. 2003 Sep-Oct;48(5):217-25.
7
Current perspectives of treatment of ductal carcinoma in situ.当前对导管原位癌治疗的看法。
Cancer Treat Rev. 2010 Nov;36(7):507-17. doi: 10.1016/j.ctrv.2010.03.007. Epub 2010 May 11.
8
Ductal carcinoma in situ. The success of breast conservation therapy: a shared experience of two single institutional nonrandomized prospective studies.导管原位癌。保乳治疗的成功:两项单机构非随机前瞻性研究的共同经验。
Surg Oncol Clin N Am. 1997 Apr;6(2):385-92.
9
Ductal carcinoma in situ of the breast - Long term results from a twenty-year cohort.乳腺导管原位癌——一项20年队列研究的长期结果
Cancer Treat Res Commun. 2018;14:17-20. doi: 10.1016/j.ctarc.2017.10.001. Epub 2017 Oct 26.
10
Local control in ductal carcinoma in situ treated by excision alone: incremental benefit of larger margins.单纯切除治疗导管原位癌的局部控制:切缘增大的额外获益
Am J Surg. 2005 Oct;190(4):521-5. doi: 10.1016/j.amjsurg.2005.06.005.

引用本文的文献

1
Predicting invasive breast cancer versus DCIS in different age groups.预测不同年龄组浸润性乳腺癌与导管原位癌的情况。
BMC Cancer. 2014 Aug 11;14:584. doi: 10.1186/1471-2407-14-584.
2
Borderline atypical ductal hyperplasia/low-grade ductal carcinoma in situ on breast needle core biopsy should be managed conservatively.乳腺针芯活检中边界性非典型性导管增生/低级别导管原位癌应保守治疗。
Am J Surg Pathol. 2013 Jun;37(6):913-23. doi: 10.1097/PAS.0b013e31828ba25c.